Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aclarion, Inc. (ACON) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aclarion, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1635077.
Total stock buying since 2022: $278,491.
Total stock sales since 2022: $0.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 1 | $1,000 | 0 | $0 | 0 | $0 |
| 2022 | 107,304 | $277,491 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-02 | 1 | $1,000 | 0 | $0 | 0 | $0 |
| 2022-12 | 40,904 | $19,652 | 0 | $0 | 0 | $0 |
| 2022-04 | 66,400 | $257,839 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-16 | Thramann Jeffrey John (Executive Chairman) | Buy | 1 | 1,000.00 | 1,000 |
| 2022-12-29 | Ness Brent (Chief Executive Officer) | Buy | 16,211 | .55 | 8,834 |
| 2022-12-29 | Lorbiecki John Paul (Chief Financial Officer) | Buy | 22,404 | .44 | 9,857 |
| 2022-12-28 | Ness Brent (Chief Executive Officer) | Buy | 2,289 | .42 | 961 |
| 2022-04-22 | Bond Ryan (Chief Strategy Officer) | Buy | 20,000 | 2.80 | 56,000 |
| 2022-04-21 | Neal David K | Buy | 34,400 | 4.35 | 149,640 |
| 2022-04-21 | Ness Brent (Chief Executive Officer) | Buy | 1,000 | 4.35 | 4,350 |
| 2022-04-21 | Wesemann William | Buy | 11,000 | 4.35 | 47,849 |
Insider trading activities including stock purchases, stock sales, and option exercises of ACON listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aclarion, Inc. (symbol ACON, CIK number 1635077) see the Securities and Exchange Commission (SEC) website.